Cite

HARVARD Citation

    Jiang, N. et al. (n.d.). Risk of gastrointestinal complications in breast cancer patients treated with neratinib: a meta-analysis. Expert opinion on drug safety. 16 (10), pp. 1111-1119. [Online]. 
  
Back to record